- Home
- RIGL vs MLR Comparison
RIGL vs MLR Comparison
Compare RIGL & MLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- MLR
- Stock Information
- Founded
- RIGL 1996
- MLR 1990
- Country
- RIGL United States
- MLR United States
- Employees
- RIGL N/A
- MLR N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- MLR Construction/Ag Equipment/Trucks
- Sector
- RIGL Health Care
- MLR Consumer Discretionary
- Exchange
- RIGL Nasdaq
- MLR Nasdaq
- Market Cap
- RIGL 537.6M
- MLR 468.2M
- IPO Year
- RIGL 2000
- MLR 1994
- Fundamental
- Price
- RIGL $41.76
- MLR $36.88
- Analyst Decision
- RIGL Buy
- MLR Buy
- Analyst Count
- RIGL 6
- MLR 2
- Target Price
- RIGL $39.83
- MLR $55.00
- AVG Volume (30 Days)
- RIGL 652.5K
- MLR 68.7K
- Earning Date
- RIGL 11-04-2025
- MLR 11-05-2025
- Dividend Yield
- RIGL N/A
- MLR 2.12%
- EPS Growth
- RIGL 2698.26
- MLR N/A
- EPS
- RIGL 6.20
- MLR 2.58
- Revenue
- RIGL $282,076,000.00
- MLR $840,260,000.00
- Revenue This Year
- RIGL $59.93
- MLR N/A
- Revenue Next Year
- RIGL N/A
- MLR $26.85
- P/E Ratio
- RIGL $6.77
- MLR $14.63
- Revenue Growth
- RIGL 79.13
- MLR N/A
- 52 Week Low
- RIGL $14.63
- MLR $33.81
- 52 Week High
- RIGL $43.72
- MLR $76.25
- Technical
- Relative Strength Index (RSI)
- RIGL 69.92
- MLR 33.57
- Support Level
- RIGL $34.00
- MLR $37.35
- Resistance Level
- RIGL $39.56
- MLR $39.00
- Average True Range (ATR)
- RIGL 2.35
- MLR 1.42
- MACD
- RIGL 1.10
- MLR -0.30
- Stochastic Oscillator
- RIGL 93.00
- MLR 0.00
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About MLR Miller Industries Inc.
Miller Industries Inc is engaged in the manufacturing of vehicle towing and recovery equipment. The company produces wreckers, car carriers, and trailer bodies under the Century, Vulcan, Challenger, Holmes, Champion, Chevron, Eagle, Titan, Jige, and Boniface brands. The products are sold in North America, Canada, and Mexico through independent distributors.